Date | Title | Description | Source |
17.04.2024 | World Hemophilia Day 2024"Equitable access for all: rec... | MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community ... | en.prnasia... |
16.04.2024 | Chinese Health Insurance Will Not Cover Drugs Like Ozempic f... | (Yicai) April 16 -- Novo Nordisk's diabetes drug Ozempic is taking the world by storm but China stre... | yicaigloba... |
11.04.2024 | Sanders speaks with Ozempic maker on price | Sen. Bernie Sanders spoke this week with the CEO of Novo Nordisk but didn't get an immediate commitm... | axios.com/... |
10.04.2024 | 3Shape Charts Sustainable Course with Release of Comprehensi... | 3Shape Charts Sustainable Course with Release of Comprehensive Sustainability Report 2023
Wed, Apr 1... | news.cisio... |
09.04.2024 | Хотите похудеть – НЕ спрашивайте меня как. Часть 2: Оземпик ... | Кратко для лиги лени: Оземпик как средство для похудения работает, но ограниченно годится для ИТ, и ... | habr.com/r... |
09.04.2024 | How the 'Oh-oh-oh Ozempic' commercial song made a musician $... | Media How the 'Oh-oh-oh Ozempic' commercial song made a musician $1 million
Peter Kafka
2024-04-09T2... | businessin... |
09.04.2024 | Novo Nordisk to acquire Cardior Pharmaceuticals and strength... | Bagsværd, Denmark, and Hannover, Germany, 25 March, 2024 – Novo Nordisk and Cardior Pharmaceuticals ... | fundplus.b... |
09.04.2024 | Merck Life Science gets new MD | Merck has appointed Dhananjay Singh as Managing Director of Merck Life Science, in India. He takes o... | thehindubu... |
08.04.2024 | Biocon leads India's push into anti-obesity drugs as patents... | Biocon Ltd. is pivoting to anti-obesity therapies as patents for the blockbuster medications start t... | business-s... |
04.04.2024 | The CEO of a weight-loss ETF that's crushing the S&P 500... | Markets The CEO of a weight-loss ETF that's crushing the S&P 500 since launching in November sha... | businessin... |
03.04.2024 | You can now get Ozempic at Costco — but don't expect big sav... | Retail You can now get Ozempic at Costco — but don't expect big savings
Alex Bitter
2024-04-03T18:10... | businessin... |
03.04.2024 | TraceLink Named to Fast Company's Annual List of the World's... | TraceLink joins the ranks of Nvidia, YouTube, OpenAI, Novo Nordisk and more
BOSTON, April 3, 2024 /P... | en.prnasia... |
26.03.2024 | Hurun Rich List: Meta's Mark Zuckerberg biggest wealth gaine... | The Hurun Research Institute has released the "Hurun Global Rich List 2024". Among global ... | business-s... |
25.03.2024 | Novo Nordisk Expands Cardio Reach by Buying Heart Drugs Biot... | Novo Nordisk is adding on to its cardiovascular drug pipeline with the acquisition of Cardior Pharma... | medcitynew... |
21.03.2024 | Medicare allows coverage of weight-loss drugs for heart cond... | Medicare will allow coverage of new weight-loss drug Wegovy to reduce the risk of heart attack and s... | axios.com/... |
21.03.2024 | Advances in Digitalization Presented at the 10th Annual Gene... | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system... | prweb.com/... |
20.03.2024 | A California millennial started secretly working 2 remote jo... | Economy A California millennial started secretly working 2 remote jobs so he could afford the Mounja... | businessin... |
19.03.2024 | Pattern named One of the World’s Most Innovative Companies | Fast Company has named Pattern to its prestigious list of the World’s Most Innovative Companies alon... | martechcub... |
19.03.2024 | Ozempic Maker Novo Nordisk to Upgrade China Insulin Plant fo... | (Yicai) March 19 -- Novo Nordisk, a major global producer of insulin and weight loss drugs, will inv... | yicaigloba... |
17.03.2024 | Weight loss drugs like Ozempic and Wegovy are fattening up D... | Economy Weight loss drugs like Ozempic and Wegovy are fattening up Denmark's economy and helped it d... | businessin... |
13.03.2024 | Global Pen Needles Market Report 2024-2034: Regional Analysi... | - | globenewsw... |
13.03.2024 | Eli Lilly teams with Amazon to offer home delivery of its Ze... | Four months after Eli Lilly obtained regulatory approval to sell its diabetes medication under a dif... | cbsnews.co... |
12.03.2024 | Hemophilia Treatment Market Poised for Growth, Forecasts Ind... | - | globenewsw... |
08.03.2024 | Global Emerging Insulin Drug and Delivery Technologies Marke... | - | globenewsw... |
08.03.2024 | FDA Approves First Treatment to Reduce Risk of Serious Heart... | For Immediate Release: March 08, 2024
Today, the U.S. Food and Drug Administration approved a new in... | einpresswi... |
08.03.2024 | Eli Lilly's new ad says weight-loss drugs shouldn't be used ... | Eli Lilly has a message for people who are taking prescription medications developed for patients wi... | cbsnews.co... |
08.03.2024 | Charted: Ozempic-maker Novo Nordisk surges on new obesity dr... | Data: YCharts; Chart: Axios Visuals
Novo Nordisk shares, already soaring on the popularity of Ozempi... | axios.com/... |
08.03.2024 | Pharmaceutical companies behind weight-loss drugs are slimmi... | Markets Pharmaceutical companies behind weight-loss drugs are slimming down a new target: The Magnif... | businessin... |
08.03.2024 | Anti-obesity drug Wegovy can be prescribed for heart problem... | Novo Nordisk's anti-obesity drug Wegovy can be prescribed to reduce the risk of cardiovascular death... | axios.com/... |
07.03.2024 | Highlights to be presented at Novo Nordisk’s Capital Markets... | - | globenewsw... |
07.03.2024 | Novo Nordisk Obesity Pill Flashes the Potential to Beat Wego... | An experimental Novo Nordisk obesity pill led to weight loss of 13.1% in a clinical trial, topping r... | medcitynew... |
07.03.2024 | Global Hemophilia Treatment Regimen and Therapy Research Rep... | - | globenewsw... |
05.03.2024 | Novo Nordisk A/S: Semaglutide 1.0 mg demonstrates 24% reduct... | - | globenewsw... |
05.03.2024 | Health | The new beauty regimen: Lose weight with Ozempic, t... | Andrea Chang | Los Angeles Times (TNS)
LOS ANGELES — Jeniffer Brown wanted the Ozempic body. She jus... | dailycamer... |
31.01.2024 | Pfizer’s reset year starts with a little profit | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
30.01.2024 | Can Wegovy treat depression as well as obesity? New research... | Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied t... | statnews.c... |
23.01.2024 | Novo Nordisk to invest €235 million in EraCal | | startuptic... |
18.12.2023 | Wegovy may have another helpful trick: fighting inflammation... | As more data emerges that obesity drugs like Wegovy can reduce complications from heart and kidney p... | statnews.c... |
06.12.2023 | A bold approach to pay for weight loss drugs for everyone wh... | The news about anti-obesity drugs keeps getting better. In November, data presented at the American ... | statnews.c... |
13.11.2023 | Novo Nordisk wants to be a cardiovascular company, too, with... | PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbust... | statnews.c... |
05.09.2023 | Business is booming for the maker of weight-loss drugs Wegov... | The Danish pharmaceutical giant makes the buzzy weight-loss drugs Wegovy and Ozempic. OLEKSANDRA TRO... | businessin... |
10.08.2023 | Ozempic maker bolsters weight loss portfolio with $1 billion... | Danish drugmaker Novo Nordisk has agreed to buy Inversago Pharma, a Montreal-based developer of anti... | axios.com/... |
08.08.2023 | Novo Nordisk’s Huge Financial Bet On Obesity Drug Wegovy Win... | Obesity is a major cause of a number of diseases: type 2 diabetes, atherosclerosis, strokes and even... | forbes.com... |
22.05.2023 | Forget Ozempic injections — a pill version of the weight los... | Health Forget Ozempic injections — a pill version of the weight loss drug could be coming soon
Hilar... | businessin... |
10.05.2023 | Why buzzy weight-loss drugs such as Ozempic and Wegovy cost ... | Semaglutide is a weekly injection that mimics a hunger-regulating hormone in the body. Insider
Redee... | businessin... |
04.05.2023 | Novo Nordisk limits distribution of low doses of Wegovy in U... | Novo Nordisk is holding back low doses of Wegovy, its recently approved obesity medication, in the U... | cbsnews.co... |
15.02.2023 | People are using life-saving diabetes drug Ozempic to lose w... | A drug used to treat Type 2 diabetes has become wildly popular due to one of its side effects: weigh... | cbsnews.co... |
15.01.2023 | 50 компаний, за акциями которых стоит следить в 2023 году Ст... | Аналитики Bloomberg составили список самых любопытных проектов, торгующихся на фондовых биржах.
4 ко... | vc.ru/fina... |
24.10.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark 24 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase prog... | globenewsw... |
17.10.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark 17 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase prog... | globenewsw... |
14.10.2022 | Novo Nordisk announces the completion of the Forma Therapeut... | Bagsværd, Denmark, 14 October 2022 – Novo Nordisk today announced that the acquisition of Forma Ther... | globenewsw... |
10.10.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark 10 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase prog... | globenewsw... |
03.10.2022 | Once-weekly insulin icodec demonstrates superior reduction i... | Bagsværd, Denmark, 3 October 2022 – Novo Nordisk today announced headline results from the ONWARDS 5... | globenewsw... |
03.10.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 3 October 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase prog... | globenewsw... |
26.09.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 26 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase p... | globenewsw... |
22.09.2022 | More people with type 2 diabetes achieved blood sugar target... | Data presented today show more participants achieved greater treatment satisfaction when switching t... | globenewsw... |
19.09.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 19 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase p... | globenewsw... |
12.09.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 12 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase p... | globenewsw... |
12.09.2022 | Six New Member Companies Join the International Consortium f... | IQ continues to grow as an organization and advance key industry initiatives while delivering innova... | prweb.com/... |
12.09.2022 | Novo Nordisk and Microsoft collaborate to accelerate drug di... | Bagsværd, Denmark and Redmond, WA, US, 12 September 2022 – Novo Nordisk and Microsoft have entered a... | globenewsw... |
05.09.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 5 September 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase pr... | globenewsw... |
01.09.2022 | Novo Nordisk to acquire Forma Therapeutics and expand presen... | Bagsværd, Denmark and Watertown, Mass, US, 01 September 2022 – Novo Nordisk and Forma Therapeutics, ... | globenewsw... |
29.08.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 29 August 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase prog... | globenewsw... |
22.08.2022 | Novo Nordisk successfully completes phase 2 trial with Cagri... | Bagsværd, Denmark, 22 August 2022 – Novo Nordisk today announced headline results from a phase 2 cli... | globenewsw... |
22.08.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 22 August 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase prog... | globenewsw... |
15.08.2022 | Novo Nordisk A/S: Share repurchase programme | Bagsværd, Denmark, 15 August 2022 – On 3 August 2022, Novo Nordisk initiated a share repurchase prog... | globenewsw... |
08.08.2022 | Novo Nordisk A/S: Trading in Novo Nordisk shares by board me... | Bagsværd, Denmark, 8 August 2022 — This document discloses the data of the transaction(s) made in No... | globenewsw... |
05.08.2022 | Novo Nordisk A/S: Trading in Novo Nordisk shares by board me... | Trading in Novo Nordisk shares by board members, executives and associated persons
Bagsværd, Denmark... | globenewsw... |
03.08.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 3 August 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programm... | globenewsw... |
29.07.2022 | Novo Nordisk achieves primary objectives of ONWARDS 3 and 4 ... | Bagsværd, Denmark, 29 July 2022 – Novo Nordisk today announced headline results from the ONWARDS 3 a... | globenewsw... |
25.07.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 25 July 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme... | globenewsw... |
18.07.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 18 July 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme... | globenewsw... |
11.07.2022 | Novo Nordisk A/S: Mim8 phase 1 & 2 data demonstrates pot... | No thromboembolic events or related serious adverse events reported over 12-week observation period ... | globenewsw... |
11.07.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 11 July 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme... | globenewsw... |
10.07.2022 | Novo Nordisk A/S: Phase 3 data for concizumab show 86% reduc... | Data presented today show a reduction in treated spontaneous and traumatic bleeds and mean annualise... | globenewsw... |
04.07.2022 | Novo Nordisk A/S: Share repurchase programme | Bagsværd, Denmark, 4 July 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme ... | globenewsw... |
27.06.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 27 June 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme... | globenewsw... |
20.06.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 20 June 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme... | globenewsw... |
13.06.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 13 June 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme... | globenewsw... |
12.06.2022 | Novo Nordisk A/S: Sogroya® data show potential as once-weekl... | Investigational phase 3 data for Sogroya® (somapacitan) injection in children with growth hormone de... | globenewsw... |
07.06.2022 | Novo Nordisk A/S: | Novo Nordisk – major shareholder announcement
Bagsværd, Denmark, 7 June 2022 – Novo Nordisk today an... | globenewsw... |
03.06.2022 | Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 ... | Bagsværd, Denmark, 3 June 2022 – Novo Nordisk today announced headline results from the main phases ... | globenewsw... |
30.05.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 30 May 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme ... | globenewsw... |
23.05.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 23 May 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme ... | globenewsw... |
16.05.2022 | Novo Nordisk A/S: Share repurchase programme | Bagsværd, Denmark, 16 May 2022 – On 3 May 2022, Novo Nordisk initiated a share repurchase programme ... | globenewsw... |
11.05.2022 | Novo Nordisk, Flagship's forward-thinking partnership aims t... | Novo Nordisk has struck up a new—and unconventional—partnership with Flagship Pioneering, aiming to ... | fiercebiot... |
11.05.2022 | Novo Nordisk A/S: Trading in Novo Nordisk shares by board me... | Bagsværd, Denmark, 11 May 2022 — This document discloses the data of the transaction(s) made in Novo... | globenewsw... |
06.05.2022 | Novo Nordisk A/S: Trading in Novo Nordisk shares by board me... | Bagsværd, Denmark, 6 May 2022 — This document discloses the data of the transaction(s) made in Novo ... | globenewsw... |
06.05.2022 | Novo Nordisk A/S: | Novo Nordisk – major shareholder announcement
Bagsværd, Denmark, 6 May 2022 – Novo Nordisk today ann... | globenewsw... |
03.05.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 3 May 2022 – On 2 February 2022, Novo Nordisk initiated a share repurchase progra... | globenewsw... |
03.05.2022 | Trading in Novo Nordisk shares by board members, executives ... | Bagsværd, Denmark, 3 May 2022 — This document discloses the data of the transaction(s) made in Novo ... | globenewsw... |
03.05.2022 | Novo Nordisk A/S: Trading in Novo Nordisk shares by board me... | Bagsværd, Denmark, 3 May 2022 — This document discloses the data of the transaction(s) made in Novo ... | globenewsw... |
03.05.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 3 May 2022 — As part of the up to DKK 24.0 billion 2022 share repurchase programm... | globenewsw... |
03.05.2022 | Novo Nordisk A/S purchases B shares worth DKK 3,402 million ... | Bagsværd, Denmark, 3 May 2022 — Novo Nordisk A/S has today entered into an agreement to purchase 4,2... | globenewsw... |
02.05.2022 | Novo Nordisk – major shareholder announcement | Bagsværd, Denmark, 2 May 2022 – Novo Nordisk today announced that the company has been notified by B... | globenewsw... |
02.05.2022 | Novo Nordisk A/S: Trading in Novo Nordisk shares by board me... | Bagsværd, Denmark, 2 May 2022 — This document discloses the data of the transaction(s) made in Novo ... | globenewsw... |
29.04.2022 | Novo Nordisk A/S – Total number of voting rights and share c... | Bagsværd, Denmark, 29 April 2022 – In accordance with Section 32 of the Danish Capital Markets Act, ... | globenewsw... |
28.04.2022 | Once-weekly insulin icodec demonstrates superior reduction i... | Bagsværd, Denmark, 28 April 2022 – Novo Nordisk today announced headline results from the ONWARDS 2 ... | globenewsw... |
27.04.2022 | Novo Nordisk A/S – Reduction of the share capital | Bagsværd, Denmark, 27 April 2022 – At Novo Nordisk’s Annual General Meeting on 24 March 2022, it was... | globenewsw... |
25.04.2022 | Novo Nordisk A/S – Share repurchase programme | Bagsværd, Denmark, 25 April 2022 – On 2 February 2022, Novo Nordisk initiated a share repurchase pro... | globenewsw... |